Literature DB >> 1120103

Negative cooperativity in the binding of thyroxine to human serum prealbumin. Preparation of tritium-labeled 8-anilino-1-naphthalenesulfonic acid.

R N Ferguson, H Edelhoch, H A Saroff, J Robbins, H J Cahnmann.   

Abstract

The binding of thyroxine (T4) and 8-anilino-1-naphthalenesulfonic acid (ANS) to human serum prealbumin was measured by equilibrium dialysis at pH 7.4 in 0.05 M phosphate-0.10 M NaCl at 25 degrees. The data were analyzed for the binding constants based on equations for (1) two independent sites and (2) two identical sites with negative interaction. Evaluation by the independent site model gave the following association constants: for T4 binding, KT1 = 1.0 x 10-8 M-1, KT2 = 9.5 x 10-5 M-1; for ANS binding, KA1 = 9.5 x 10-5 M-1, KA2 = 2.1 x 10-5 M-1. The interactive model gave constants kT = 5.5 x 10-7 M-1 and kA = 5.5 x 10-5 M-1. Interaction factors, alpha, defined such that -RT in alpha is the energy of interaction, were: alpha T = 0.041 AND ALPHA A = 0.62 for T4 and ANS, respectively. The "best fit" values for the number of sites were 2.0 and 1.6 for T4 and ANS, respectively. The binding of T4 to human prealbumin was competitive with ANS, and the binding constants evaluated from competition experiments were in agreement with those found for each ligand when studied separately. On the basis of analysis of X-ray data of human prealbumin (Blake et al.) there appear to be two identical T4 sites. It is therefore evident that the binding of T4 represents a case of negative cooperativity which is presumably due to interaction between ligands.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1120103     DOI: 10.1021/bi00673a014

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  31 in total

1.  Unfolding and refolding of juvenile hormone binding protein.

Authors:  Piotr Dobryszycki; Robert Kołodziejczyk; Daniel Krowarsch; Jacek Gapiński; Andrzej Ozyhar; Marian Kochman
Journal:  Biophys J       Date:  2004-02       Impact factor: 4.033

2.  Identification of a sulfate metabolite of PCB 11 in human serum.

Authors:  Fabian A Grimm; Hans-Joachim Lehmler; Wen Xin Koh; Jeanne DeWall; Lynn M Teesch; Keri C Hornbuckle; Peter S Thorne; Larry W Robertson; Michael W Duffel
Journal:  Environ Int       Date:  2016-11-03       Impact factor: 9.621

3.  Binding of perlecan to transthyretin in vitro.

Authors:  S Smeland; S O Kolset; M Lyon; K R Norum; R Blomhoff
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

Review 4.  Current and future treatment of amyloid diseases.

Authors:  M Ankarcrona; B Winblad; C Monteiro; C Fearns; E T Powers; J Johansson; G T Westermark; J Presto; B-G Ericzon; J W Kelly
Journal:  J Intern Med       Date:  2016-05-10       Impact factor: 8.989

Review 5.  The transthyretin amyloidoses: from delineating the molecular mechanism of aggregation linked to pathology to a regulatory-agency-approved drug.

Authors:  Steven M Johnson; Stephen Connelly; Colleen Fearns; Evan T Powers; Jeffery W Kelly
Journal:  J Mol Biol       Date:  2012-01-05       Impact factor: 5.469

6.  Retinol-binding protein and transthyretin mRNA levels in visceral yolk sac and liver during fetal development in the rat.

Authors:  D R Soprano; K J Soprano; D S Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

7.  Transthyretin Binding Heterogeneity and Anti-amyloidogenic Activity of Natural Polyphenols and Their Metabolites.

Authors:  Paola Florio; Claudia Folli; Michele Cianci; Daniele Del Rio; Giuseppe Zanotti; Rodolfo Berni
Journal:  J Biol Chem       Date:  2015-10-14       Impact factor: 5.157

8.  A marker for primary choroid plexus neoplasms.

Authors:  J Herbert; T Cavallaro; A J Dwork
Journal:  Am J Pathol       Date:  1990-06       Impact factor: 4.307

9.  A homozygous transthyretin variant associated with senile systemic amyloidosis: evidence for a late-onset disease of genetic etiology.

Authors:  D R Jacobson; P D Gorevic; J N Buxbaum
Journal:  Am J Hum Genet       Date:  1990-07       Impact factor: 11.025

10.  Transthyretin is an inhibitor of monocyte and endothelial cell interleukin-1 production.

Authors:  L Borish; M S King; J J Mascali; S Johnson; B Coll; L J Rosenwasser
Journal:  Inflammation       Date:  1992-10       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.